As of November 10, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Aspira Women's Health Inc. The largest reported stake is Schuler Jack W's, at 8.7%. 2 filings are on record since September 19, 2025 (Schedule 13D/A, June 11, 2026).
Sell to companies like Aspira Women's Health Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Aspira Women's Health Inc. has 2 Schedule 13D or 13G filings on record since 2025-09-19. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 8.7% | 4,052,587 | SCHEDULE 13D/A, 2026-06-11 | 2026-06-05 |
Holding shares or following this stake? See who's behind Aspira Women's Health Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Aspira Women's Health Inc. and the records around it.
Aspira Women's Health Inc. elsewhere on the record
- Leadership changes Jul 2026
- Company profile and every filing Jun 2026
- Form D filing Jun 2026
- Form D filing Sep 2025
- Who owns it
Companies that share a holder
- SCHULER JACK W also filed stake reports on 1 other company: BIODESIX INC (Jan 2026)
Watch Aspira Women's Health Inc.
Get an email when Aspira Women's Health Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Aspira Women's Health Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Aspira Women's Health Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aspira Women's Health Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Schuler Jack W | 6,536 | 4,046,051 | 6,536 | 4,046,051 | SCHEDULE 13D/A, 2026-06-11 |
| Jack W. Schuler Living Trust | 0 | 4,046,051 | 0 | 4,046,051 | SCHEDULE 13D/A, 2026-06-11 |
The latest filing identifies Aspira Women's Health Inc. by CUSIP 04537Y208 and gives its principal executive office as 12117 BEE CAVES ROAD BUILDING THREE, Suite 100, Austin, TX 78738 (SCHEDULE 13D/A, 2026-06-11).
Purpose of Transaction (Item 4)
Schuler Jack W
This Amendment No. 19 to Schedule 13D (this "Amendment") hereby amends and supplements Item 4 by adding the following thereto: "The disclosure set forth in Items 5 and 6 below is hereby incorporated by reference in this Item 4. On June 5, 2026, the Trust purchased from the Issuer the Common Stock and June 2026 Warrants pursuant to the June 2026 Purchase Agreement (in each case as defined and further described in Item 6 below)."Item 4 of the SCHEDULE 13D/A filed 2026-06-11
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-09-19 | Schuler Jack W | 9.1% | SCHEDULE 13D/A |
| 2026-06-11 | Schuler Jack W | 8.7% | SCHEDULE 13D/A |
Questions about who owns Aspira Women's Health Inc.
Who owns Aspira Women's Health Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Aspira Women's Health Inc.: Schuler Jack W (8.7%, Schedule 13D/A, filed 2026-06-11).
When did Schuler Jack W buy into Aspira Women's Health Inc.?
The filings give report dates, not purchase dates. The earliest filing from Schuler Jack W on this page is the Schedule 13D/A, filed 2025-09-19, reporting 9.1%; its latest, Schedule 13D/A filed 2026-06-11, reports 8.7%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Aspira Women's Health Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 7, 2026 | Leadership change: Michael Buhle departs, Chief Executive Officer | — | Leadership changes | Source |
| June 22, 2026 | Form D, private offering | $1.49M sold | Form D page | Source |
| June 22, 2026 | Leadership change: Michael Buhle departs, Chief Executive Officer, and 1 more | — | Leadership changes | Source |
| April 30, 2026 | Leadership change: John Strahley appointed, Chief Financial Officer and Chief Accounting Officer | — | Leadership changes | Source |
| September 18, 2025 | Form D, private offering | $2.95M sold | Form D page | Source |
| March 20, 2025 | Form D, private offering | $1.37M sold | Form D page | Source |
Aspira Women's Health Inc.: every filing and event
Tools for this story
Each opens in a new tab, filled in for Aspira Women's Health Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.